Founded in 2000 and based in Waltham, Massachusetts, Echelon Ventures focuses on investing in startups in the pharmaceutical and genetics fields. With an average deal size ranging from $10 to $50 million, Echelon Ventures has a higher than average lead investment amount compared to other organizations. The fund typically invests in less than 2 deals per year and has had a significant number of exits in 2019. Some of the notable portfolio startups include BioTrove and Avedro, and the fund prefers to invest in companies that are 4-5 years old. Echelon Ventures primarily invests in rounds with 4-5 participants and has received investment from sponsors such as Prism Venture Management and DeNovo Ventures. The fund is mainly focused on investments in the United States.